Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.00
Bid: 16.90
Ask: 17.98
Change: 0.00 (0.00%)
Spread: 1.08 (6.391%)
Open: 17.00
High: 17.00
Low: 17.00
Prev. Close: 17.00
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Development Agreement

23 Sep 2009 07:00

RNS Number : 4997Z
Nanoco Group PLC
23 September 2009
 
For immediate release
23 September 2009
 
 
NANOCO GROUP PLC
(“Nanoco” or “the Company”)
 
Signs Agreement with Major Japanese Electronics Company
Nanoco Group plc (AIM: NANO), a world leader in the development and manufacture of commercial quantities of quantum dots, announces that it has signed a joint development agreement with a major Japanese electronics company under which it will design and develop quantum dots for use in light emitting diodes (LEDs) in liquid crystal display (LCD) televisions. 
Nanoco will receive an upfront payment and milestone payments under the terms of the agreement and, on completion of the 18-month development work, it is expected that a supply and licence agreement will be signed. 
The structure of this agreement is similar to an earlier agreement with another major Japanese corporation active in the LCD display and general lighting markets. The earlier agreement comprised a total of $1.2 million in joint development payments during a 12-month period. The development work was successful and a supply and licence agreement followed, from which a further US$8 million in milestone payments is expected by 31 December 2010.
It is anticipated that Nanoco will sign further agreements with companies active in the LED market in due course. 
The use of LEDs as the backlight for LCD displays and in general lighting allows a substantial reduction in the power consumed. Quantum dots offer key advantages over the phosphors currently used to create white light from LEDs including superior colour performance. 
Michael Edelman, Nanoco’s Chief Executive Officer, commented: “We are delighted to enter into this agreement with a major company aimed at using our quantum dots in LCD TVs. This follows an earlier agreement with another major corporation, which is progressing well. We anticipate signing further deals in the LED market. This represents just one of the key areas in which we are making rapid progress in the commercialisation of our quantum dot development, scale up and manufacturing technology.”
For further information please contact:
 
Nanoco
+ 44 (0) 161 603 7900
Michael Edelman, Chief Executive Officer
 
 
 
Zeus Capital
+ 44 (0) 161 831 1512
Alex Clarkson
 
Nick Cowles
 
 
 
Buchanan Communications
+ 44 (0) 20 7466 5000
Mark Court / Jennie Spivey / Miranda Higham 
 
 
 
Notes for editors:
 
About Nanoco Group plc
Nanoco is a world leader in the development and manufacture of commercial quantities of quantum dots for use in multiple applications including solid-state lighting, solar cells and biological imaging.Nanoco’s quantum dots, which are free of heavy metals and comply with RoHS legislation, can be combined into a wide range of materials including liquids, polymers and glass.
 
Nanoco forms strategic partnerships with major end users across a range of applications.
 
Nanoco was founded in 2001 and is based in Manchester, UK. It also has an office in Tokyo, Japan. Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO.
 
About quantum dots
Quantum dots are fluorescent nano-sized particles of semiconductor material which have the ability to emit light in a specific colour dependent on the size of the particle.
 
 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRDGGZLLZRGLZM
Date   Source Headline
30th Aug 20223:28 pmRNSDirector/PDMR Shareholding
25th Aug 20221:36 pmRNSDirector/PDMR Shareholding
23rd Aug 20222:22 pmRNSFunded Law Suit Filed in Germany
19th Aug 20228:21 amRNSLitigation Update – Pre-Trial Conference
18th Aug 20224:10 pmRNSDirector/PDMR Shareholding
16th Aug 20227:00 amRNSTrading Update
28th Jul 202210:42 amRNSHolding(s) in Company
13th Jul 20222:03 pmRNSReplacement - Director/PDMR Shareholding
13th Jul 202212:00 pmRNSHolding(s) in Company
13th Jul 202212:00 pmRNSDirector/PDMR Shareholding
13th Jul 202212:00 pmRNSHolding(s) in Company
30th Jun 20227:00 amRNSTotal Voting Rights
29th Jun 20227:00 amRNSChange of Auditor
23rd Jun 20223:48 pmRNSDirector/PDMR Shareholding
22nd Jun 20222:25 pmRNSHolding(s) in Company
21st Jun 20223:36 pmRNSDirector/PDMR Shareholding
21st Jun 20229:06 amRNSReplacement: Director/PDMR Shareholding
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
17th Jun 20224:36 pmRNSPrice Monitoring Extension
17th Jun 202210:45 amRNSHolding(s) in Company
14th Jun 20229:42 amRNSHolding(s) in Company
9th Jun 20227:00 amRNSBlock listing Six-monthly Return
8th Jun 202212:00 pmRNSResults of Fundraise
8th Jun 20227:00 amRNSFundraise significantly over-subscribed
7th Jun 20225:16 pmRNSReplacement: Litigation Update
7th Jun 20224:55 pmRNSLitigation Update
6th Jun 20227:02 amRNSTrading Update & Proposed Fundraise
6th Jun 20227:00 amRNSMajor Work Package for European Customer
23rd May 20225:00 pmRNSHolding(s) in Company
17th May 20227:02 amRNSLitigation Update
13th May 202212:15 pmRNSHolding(s) in Company
13th Apr 20222:49 pmRNSHolding(s) in Company
12th Apr 20227:00 amRNSInterim Results
17th Mar 20227:00 amRNSAdditional Work Package for European Customer
15th Mar 20227:00 amRNSNotice of Interim Results
4th Feb 20223:14 pmRNSHolding(s) in Company
31st Jan 20227:00 amRNSTotal Voting Rights
9th Dec 20217:00 amRNSBlock listing Six-Monthly Return
2nd Dec 20217:18 amRNSBlock Listing Application
1st Dec 202112:30 pmRNSDirector/PDMR Shareholding
1st Dec 202112:28 pmRNSAnnual General Meeting – Voting Results
30th Nov 20217:00 amRNSAGM Statement
18th Nov 20211:13 pmRNSDirector/PDMR Shareholding
9th Nov 20217:11 amRNSDirector/PDMR Shareholding
8th Nov 20217:00 amRNSDirector Appointment
5th Nov 202111:25 amRNSAdditional Work Package for European Customer
4th Nov 20216:20 pmRNSNotice of AGM
3rd Nov 20217:00 amRNSPreliminary Results
18th Oct 20216:10 pmRNSChange to final results announcement date
13th Oct 20219:30 amRNSPresentation via Investor Meet Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.